tiprankstipranks
Trending News
More News >

4DMedical Reports Strong Revenue Growth and Strategic Advancements in Q3 FY2025

Story Highlights
  • 4DMedical Limited reported a 103% increase in operating revenue for FY2025.
  • The company is preparing for FDA submission of its CT:VQ™ product, attracting significant interest.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
4DMedical Reports Strong Revenue Growth and Strategic Advancements in Q3 FY2025

Don’t Miss TipRanks’ Half-Year Sale

4DMedical Ltd ( (AU:4DX) ) has provided an announcement.

4DMedical Limited reported a significant increase in operating revenue for the year-to-date FY2025, achieving a 103% rise compared to the previous period, with gross margins of 91.4%. The company is expanding its sales pipeline and has secured key contracts, including a renewal with the Cleveland Clinic and conversions of pilot programs into commercial contracts. A cost reduction program has been implemented, resulting in $6.5 million in annualized savings. The company is preparing for the FDA submission of its CT:VQ™ product, which has attracted interest from major medical centers and industry collaborators. Additionally, 4DMedical has received regulatory clearance for its CT LVAS™ in Canada and has been highlighted by Philips as a solution for improving veteran health outcomes.

More about 4DMedical Ltd

4DMedical Limited is a company specializing in respiratory imaging technology, focusing on providing innovative solutions for lung health. The company offers Software-as-a-Service (SaaS) products and has a significant presence in both the U.S. and Australian markets, with a growing global footprint.

YTD Price Performance: -41.67%

Average Trading Volume: 955,430

Technical Sentiment Signal: Buy

Current Market Cap: A$126.2M

See more data about 4DX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1